MedPath
NMPA Approval

Levosimendan Injection

国药准字H20243548

April 17, 2024

Drug Information

左西孟旦注射液

注射剂

5ml∶12.5mg

化学药品

April 17, 2024

Company Information

Applicant Company

成都高新区高朋东路16号

Manufacturing Company

吉林省梅河口市梧桐路1688号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左西孟旦注射液 - NMPA 批准文号 | MedPath